🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Primary Ciliary Dyskinesia in Adult Bronchiectasis

RecruitingNAAges 18 Years - anyAllIndiana University
NCT07566611 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to help determine how often primary ciliary dyskinesia (PCD) is present but undiagnosed in adults with bronchiectasis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults (≥18) with CT-confirmed bronchiectasis Exclusion Criteria: * Pre-existing diagnosis of cystic fibrosis * Pre-existing diagnosis of primary ciliary dyskinesia * Inability to perform testing * Refusal of consent
💊

What it tests

  • Nasal Nitric Oxide Measurement
  • Nasopharyngeal (Nasal) Samples
📍

Where

1 site
Riley Hospital for Children
Indianapolis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy